Nuvalent

1 follower


Nuvalent is creating precisely targeted therapies for patients with cancer designed to overcome the limitations of existing therapies for clinically proven kinase targets. Leveraging deep expertise in structure-based design, Nuvalent develops innovative small molecules with exquisite target selectiv... Read more

Employees

11-50

Links


Org chart

Collapse
Deb Miller
Chief Legal Officer
Darlene Noci
Chief Development Officer
Henry Pelish
SVP, Drug Discovery
Jessie Lin
VP, Corporate Strategy & Portfolio Management
Matthew Metivier
VP, Human Resources
Philip Engel
Director, Cybersecurity & Compliance

Board & advisors

Matthew D. Shair
Founder & Head Scientific Advisor
Gary Gilliland
Independent Director
Sapna Srivastava
Independent Board Member
Nancy Kohl
Scientific Advisor
D. Ross Camidge
Scientific Advisor
Michael Meyers
Independent Board Member
Pasi Jänne
Scientific Advisor
Aaron Hata
Scientific Advisor
Alexander Drilon
Scientific Advisor

Teams


Offices